PROGRAMME
Programme will be furnished shortly.
Please check this page for updates when the programme is released!
Kindly note that the programme is tentative and may be subject to changes.
CONFERENCE DAY 1
Date: 15 May 2026 (Friday)
Venue: Academia, SGH Campus, 20 College Road, Singapore 169856
Kindly note that the programme is tentative and may be subject to changes.
CONGRESS DAY 1
Date: 14 August 2025 (Thursday)
Venue: The Ngee Ann Kongsi (NAK) Auditorium, Academia, SGH Campus, 20 College Road, Singapore 169856
Time (in SGT)
Programme
Speaker
0800 - 0850
Welcome Reception and Registration
0900 - 0930
Conference Opening
Delivering on the Promise of Cell Therapy in Asia – Quality, Access, Affordability
Dr Cheong Wei Yang
Guest-of-Honour, ACTRIS Committee Chairman
0930 - 1020
Plenary Session
The Current Landscape of Cell and Gene Therapy
Chairpersons: Prof Akihiro Shimosaka and Prof Mickey B C Koh
0930 - 0955
The GoCART Coalition
Prof Christian Chabannon
Institut Paoli-Calmettes Comprehensive Cancer Center, France
0955 - 1020
The New EU Regulation on Substances of Human Origin (SoHO)
Dr Stefaan Van Der Spiegel
Sector - Substance of Human Origin (SoHO - blood, tissue, cells, organs), European Commission, Belgium
1020 - 1050
Morning Tea Break
IMMUNE CELL THERAPY SESSION 1 - CAR-T Therapy / TILs
Chairperson: Clin Asst Prof Chen Yunxin
1050 - 1110
CD7 CAR-T for Treating Hematological Malignancies
Dr Peggy Lu
Lu Daopei Hospital, China
1110 - 1130
Advancing CAR T-cell Success in Lymphomas
Dr Ong Shin Yeu
Singapore General Hospital, Singapore
1130 - 1150
TILs in Solid Tumours
Asst Prof Sophia Wong
National Cancer Centre Singapore, Singapore
1150 - 1210
IPS Derived T-cell Therapy
Prof Shin Kaneko
Kyoto University, Japan
1210 - 1220
Question and Answer
All Speakers
1220 - 1350
Lunch Break
1250 - 1350
Sponsored Seminar Session by Miltenyi Biomedicine
Zamtocabtagene Autoleucel (Zamto-cel): Global and APAC Developments and Insights
by Dr Linda Hanssens
Innovative Approaches in CAR-T Cell Programs in China and Singapore
by Prof Leung Wing Hang
Clinical Insights and Experiences with CAR-T Therapies
by Prof Mickey B C Koh
Chairperson: Dr Linda Hanssens
GENE THERAPY SESSION
Chairperson: A/Prof Citra Mattar
1350 - 1410
In vivo Genome Editing Treatment for Monogenetic Diseases
Prof Tsukasa Ohmori
Jichi Medical University School of Medicine, Japan
1410 - 1430
Thalassemia
Prof Suradej Hongeng
Bumrungrad International Hospital, Thailand
1430 - 1450
Next Generation iPSC-derived Platelet Product
Prof Koji Eto
Kyoto University, Japan
1450 - 1500
Question and Answers
All Speakers
1500 - 1530
Afternoon Tea Break
IMMUNE CELL THERAPY SESSION 2 - MSCs and Exosomes (Immunomodulation)
Chairperson: Prof Mickey B C Koh
1530 - 1550
Treating Neurodegenerative Disorders with Allogeneic Platelet-based Therapy
Distinguished Prof Thierry Burnouf
Taipei Medical University, Taiwan
1550 - 1610
MSC Exosomes in Disease Modulation: Immunity as the Common Denominator
Uncovering how immune pathway modulation drives the broad therapeutic potential of MSC-derived extracellular vesicles
Dr Lim Sai Kiang
Paracrine Therapeutics, Singapore
1610 - 1630
MSC 2.0: Non-Viral Gene-Modified Stem Cells in the Translational Pipeline for Oncology
A/Prof Too Heng-Phon
Bioprocess Technology Institute, A*STAR, Singapore
1630 - 1650
Mesenchymal Stem / Stromal Cell (MSC) Therapy for Cardiovascular Disease
Dr Wannhsin Chen
Hexun Biosciences, Taiwan
1650 - 1700
Question and Answers
All Speakers
1700 - 1730
Sponsored Seminar Session by Shibuya Corporation
Cell Culturing System for Industrialization
by Mr Masataka Watanabe
1800 - 2100
Speakers' Dinner (For invited guests only)
End of Day 1
